Baltimore pharmaceutical company acquiring North Carolina firm for at least $27 million
November 17, 2017 at 10:16 AM EST
Steven Boyd, majority shareholder and Cerecor board member, said this acquisition will help the company in its shift towards a focus on pediatric health care.
